Buket Grau brings more than 20 years of commercial, strategic, and operations experience in the healthcare industry. She is currently Head of the Early and External Product Commercialization group at Biogen. Previously at Biogen, Ms. Grau served as Asset Executive for the Acute Neurology, Epilepsy and Pain franchises and for TYSABRI. Prior to Biogen, Ms. Grau held global strategic marketing positions at Stryker Corporation and international marketing and brand management positions at Procter & Gamble, Citigroup, and Dogus Group. Ms. Grau is Chair Emeritus and previously served as President and Board Director at the Healthcare Businesswomen’s Association (HBA). She was selected as one of the top 15 emerging pharmaceutical leaders by Pharmaceutical Executive magazine in 2013. Ms. Grau earned her B.S. in Biological Sciences from Orta Dogu Technical University (Turkey), received her Medical Devices Regulatory Affairs Certificate from the Regulatory Affairs Professional Society, and completed the Executive Leadership Program at Harvard Business School.